HomeCompareCBAY vs PEP

CBAY vs PEP: Dividend Comparison 2026

CBAY yields 6.16% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEP wins by $111.9K in total portfolio value· pulled ahead in Year 5
10 years
CBAY
CBAY
● Live price
6.16%
Share price
$32.48
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.0K
Annual income
$911.52
Full CBAY calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — CBAY vs PEP

📍 PEP pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBAYPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBAY + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBAY pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBAY
Annual income on $10K today (after 15% tax)
$523.40/yr
After 10yr DRIP, annual income (after tax)
$774.79/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, PEP beats the other by $51,819.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBAY + PEP for your $10,000?

CBAY: 50%PEP: 50%
100% PEP50/50100% CBAY
Portfolio after 10yr
$86.0K
Annual income
$31,393.60/yr
Blended yield
36.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

CBAY
Analyst Ratings
11
Buy
12
Hold
Consensus: Hold
Altman Z
12.9
Piotroski
4/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBAY buys
0
PEP buys
0
No recent congressional trades found for CBAY or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBAYPEP
Forward yield6.16%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$30.0K$141.9K
Annual income after 10y$911.52$61,875.67
Total dividends collected$7.7K$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples
Analyst consensusHoldHold

Year-by-year: CBAY vs PEP ($10,000, DRIP)

YearCBAY PortfolioCBAY Income/yrPEP PortfolioPEP Income/yrGap
1$11,316$615.76$10,849$509.42+$467.00CBAY
2$12,759$651.20$11,969$750.47+$790.00CBAY
3$14,338$686.22$13,500$1,124.14+$838.00CBAY
4$16,063$720.72$15,680$1,721.66+$383.00CBAY
5← crossover$17,942$754.57$18,929$2,715.34$987.00PEP
6$19,985$787.70$24,023$4,450.80$4.0KPEP
7$22,204$820.02$32,510$7,669.92$10.3KPEP
8$24,610$851.47$47,709$14,093.60$23.1KPEP
9$27,215$881.98$77,415$28,083.48$50.2KPEP
10$30,031$911.52$141,922$61,875.67$111.9KPEP

CBAY vs PEP: Complete Analysis 2026

CBAYStock

CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of primary biliary cholangitis (PBC), as well as has completed Phase 2b clinical study to treat patients with nonalcoholic steatohepatitis. The company also develops MBX-2982, which is in Phase 2a clinical study for the disease/condition of hypoglycemia in type 1 diabetics. It has a license agreement with ABW Cyclops SPV LP to support development of seladelpar for the treatment of PBC; and holds a worldwide license from Janssen Pharmaceuticals, Inc. to research, develop, and commercialize compounds with activity against an undisclosed metabolic disease target. The company was formerly known as Metabolex, Inc. CymaBay Therapeutics, Inc. was incorporated in 1988 and is headquartered in Newark, California.

Full CBAY Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this CBAY vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBAY vs SCHDCBAY vs JEPICBAY vs OCBAY vs KOCBAY vs MAINCBAY vs MOCBAY vs PMCBAY vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.